Form D · Biotechnology

Smisson-Cartledge Biomedical, LLC

Macon, GA · CIK 0001507992

Offering snapshot reported Jul 27, 2012 · SEC filing

Reported sold
$2M
Offering amount: $2M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 10, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 27, 2012Initial$2,000,000No comparison1SEC filing
May 21, 2012Initial$1,000,000No comparison1SEC filing
Nov 16, 2011Initial$316,595No comparison8SEC filing
Dec 16, 2010Initial$116,397No comparison12SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-181914

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
N/ANone

Source: Form D, filed Jul 27, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Richard G. Cartledge, M.D. Director, Executive, Promoter
Calder B. Clay Iii Director, Executive, Promoter
Christopher T. Collins Director, Promoter
David C. Field Director, Executive, Promoter
Thomas W. Glasgow, Jr. Director
Ted Graham Director
Hugh F. Smisson Iii, M.D. Director, Executive, Promoter
Steve Zenczak Director
Steve Zenezak Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
487 Cherry Street 3 Rd Floor
Macon, GA, 31201